Your position:m.limatoxi.com >> EN >> EN >> Formulation >> Eli Lilly Tirzepatides Phase III trial in obese or overweight adult patients in China was successful >> article
 
Eli Lilly Tirzepatides Phase III trial in obese or overweight adult patients in China was successful
Editor:xuezhe     Clicks:0    Date:2023-2-10 15:21:52
Keyword: Lilly
Healthoo Information:
Eli Lilly Tirzepatides Phase III trial in obese or overweight adult patients in China was successful
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • Lilly gave up the overseas rights interests of Cindilimab, Cinda PD-1 ...
  • Lilly wins FDA expedited approval for Retevmo
  • Eli Lilly Sale of Antibiotics Brands to Eddingpharm
  • Eli Lilly sets up innovation center in Dalian
  • Eli Lilly opened a drug research center&...
  • Lilly intends to form commercial partnerships...
  • Eli Lilly plans to introduce over 10&nbs...
  • Competition pattern of Duloxetine formula
  • Eli Lilly to continue venture investment ...
  • Hutchison formed collaboration with Lilly
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map